Regulation of IL-15-stimulated TNF-α production by rolipram

Journal of Immunology

Volumn 163, Issue 5, 1999, Pages 2836-2843

  Kasyapa, Chitta S ^a   Stentz, Carrie L ^a   Davey, Michael P ^a   Carr, Daniel W ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; CD69 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 15; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-15; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGES; PYRROLIDINONES; ROLIPRAM; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; THIONUCLEOTIDES; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 0033198140     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Eigler, A., B. Sinha, G. Hartmann, and S. Endres. 1997. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol. Today 18:487.
2. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397.
3. Cunnane, G., K. M. Hummel, U. Muller-Ladner, R. E. Gay, and S. Gay. 1998. Mechanism of joint destruction in rheumatoid arthritis. Arch. Immunol. Ther. Exp. 46:1.
4. Feldmann, M., M. J. Elliott, J. N. Woody, and R. N. Maini. 1997. Anti-tumor necrosis factor-α therapy of rheumatoid arthritis. Adv. Immunol. 64:283.
5. Feldmann, M., F. M. Brennan, M. J. Elliott, R. O. Williams, and R. N. Maini. 1995. TNF α is an effective therapeutic target for rheumatoid arthritis. Ann. NY Acad. Sci. 766:272.
6. Elliott, M. J., M. Feldmann, and R. N. Maini. 1995. TNF α blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action. Int. J. Immunopharmacol. 17:141.
7. van den Berg, W. B., and P. L. van Lent. 1996. The role of macrophages in chronic arthritis. Immunobiology 195:614.
8. Firestein, G. S., and N. J. Zvaifler. 1990. How important are T cells in chronic rheumatoid synovitis? [Published erratum appears in 1990 Arthritis Rheum. 33: 1437.] Arthritis Rheum. 33:768.
9. Gregersen, P. K., J. Silver, and R. J. Winchester. 1987. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:1205.
10. Staines, N. A., and P. H. Wooley 1994. Collagen arthritis: what can it teach us? Br. J. Rheumatol. 33:798.
11. Landis, R. C., M. L. Friedman, R. I. Fisher, and T. M. Ellis. 1991. Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals. J. Immunol. 146:128.
12. Parry, S. L., M. Sebbag, M. Feldmann, and F. M. Brennan. 1997. Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-α. J. Immunol. 158:3673.
13. Duke, O., G. S. Panayi, G. Janossy, and L. W. Poulter. 1982. An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin. Exp. Immunol. 49:22.
14. McInnes, I. B., J. al-Mughales, M. Field, B. P. Leung, F. P. Huang, R. Dixon, R. D. Sturrock, P. C. Wilkinson, and F. Y. Liew. 1996. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2:175.
15. Wilkinson, P. C., and F. Y. Liew. 1995. Chemoattraction of human blood T lymphocytes by interleukin-15. J. Exp. Med. 181:1255.
16. Waldmann, T., Y. Tagaya, and R. Bamford. 1998. Interleukin-2, interleukin-15, and their receptors. Int. Rev. Immunol. 16:205.
17. Nieto, M., M. A. del Pozo, and F. Sanchez-Madrid. 1996. Interleukin-15 induces adhesion receptor redistribution in T lymphocytes. Eur. J. Immunol. 26:1302.
18. Kanegane, H., and G. Tosato. 1996. Activation of naive and memory T cells by interleukin-15. Blood 88:230.
19. Oppenheimer-Marks, N., R. I. Brezinschek, M. Mohamadzadeh, R. Vita, and P. E. Lipsky. 1998. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo. J. Clin. Invest. 101:1261.
20. McInnes, I. B., B. P. Leung, R. D. Sturrock, M. Field, and F. Y. Liew. 1997. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat. Med. 3:189.
21. Testi, R., J. H. Phillips, and L. L. Lanier. 1989. T cell activation via Leu-23 (CD69). J. Immunol. 143:1123.
22. Giri, J. G., S. Kumaki, M. Ahdieh, D. J. Friend, A. Loomis, K. Shanebeck, R. DuBose, D. Cosman, L. S. Park, and D. M. Anderson. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J. 14:3654.
23. Ruchatz, H., B. P. Leung, X. Q. Wei, I. B. McInnes, and F. Y. Liew. 1998. Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J. Immunol 160:5654.
24. Wachtel, H. 1983. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors. Neuropharmacology 22:267.
25. Nyman, U., A. Mussener, E. Larsson, J. Lorentzen, and L. Klareskog. 1997. Amelioration of collagen II-induced arthritis in rats by the type IV phosphodiesterase inhibitor Rolipram. Clin. Exp. Immunol. 108:415.
26. Ross, S. E., R. O. Williams, L. J. Mason, C. Mauri, L. Marinova-Motafchieva, A. M. Malfait, R. N. Maini, and M. Feldmann. 1997. Suppression of TNF-α expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram. J. Immunol. 159:6253.
27. Hasko, G., C. Szabo, Z. H. Nemeth, A. L. Salzman, and E. S. Vizi. 1998. Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent. Eur. J. Immunol. 28:468.
28. Seldon, P. M., P. J. Barnes, K. Meja, and M. A. Giembycz. 1995. Suppression of lipopolysaccharide-induced tumor necrosis factor-α generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. Mol. Phamacol. 48:747.
29. Hasko, C., T. P. Shanley, G. Egnaczyk, Z. H. Nemeth, A. L. Salzman, E. S. Vizi, and C. Szabo. 1998. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1α via a β adrenoceptor mediated mechansism. Br J. Pharmacol. 125:1297.
30. Semmler, J., H. Wachtel, and S. Endres. 1993. The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cells. Int. J. Immunopharmacol. 15:409.
31. Sinha, B., J. Semmler, T. Eisenhut, A. Eigler, and S. Endres. 1995. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur. J. Immunol. 25:147.
32. Greten, T. F., B. Sinha, C. Haslberger, A. Eigler, and S. Endres. 1996. Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-α synthesis. Eur. J. Pharmacol. 299:229.
33. Sebbag, M., S. L. Parry, F. M. Brennan, and M. Feldmann. 1997. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-α, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis. Eur. J. Immunol. 27:624.
34. Bruynzeel, I., L. M. van der Raaij, R. Willemze, and T. J. Stoof. 1997. Pentoxifylline inhibits human T-cell adhesion to dermal endothelial cells. Arch. Dermatol. Res. 289:189.
35. Brennan, F. M., and M. Feldmann. 1992. Cytokines in autoimmunity. Curr. Opin. Immunol. 4:754.
36. Paleolog, E. M., G. R. Aluri, and M. Feldmann. 1992. Contrasting effects of interferon γ and interleukin 4 on responses of human vascular endothelial cells to tumour necrosis factor α. Cytokine 4:470.
37. Sadeghi, R., C. M. Hawrylowicz, Y. Chernajovsky, and M. Feldmann. 1992. Synergism of glucocorticoids with granulocyte macrophage colony stimulating factor (GM-CSF) but not interferon γ (IFN-γ) or interleukin-4 (IL-4) on induction of HLA class II expression on human monocytes. Cytokine 4:287.
38. Feldmann, M., F. M. Brennan, R. O. Williams, A. P. Cope, D. L. Gibbons, P. D. Katsikis, and R. N. Maini. 1992. Evaluation of the role of cytokines in autoimmune disease: the importance of TNF α in rheumatoid arthritis. Prog. Growth Factor Res. 4:247.
39. Panayi, G. S. 1997. T-cell-dependent pathways in rheumatoid arthritis. Curr. Opin. Rheumatol. 9:236.
40. Alleva, D. G., S. B. Kaser, M. A. Monroy, M. I. Fenton, and D. I. Beller. 1997. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J. Immunol. 159:2941.
41. Kammer, G. M. 1988. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9:222.